Tivic Health Systems Receives Three New Patents From USPTO And EPO; Advances In Bioelectronic Medicine
Tivic Health Systems Receives Three New Patents From USPTO And EPO; Advances In Bioelectronic Medicine
Tivic Health Systems從美國專利商標局和歐洲專利局獲得了三項新專利;在生物電子醫學方面取得了進展。
- US Patent 12,011,592 and European Patent EP3615133, both titled "Adaptive Trigger For a Microcurrent Stimulation Device", protect device and methods that the company uses to identify preferred treatment points and trigger a treatment mode. Triggers can be programmed in various ways to improve device performance and ease of use.
- European Patent EP3615134 entitled "Sinus Treatment Device With Adaptive Circuit" protects the device and methods that the company uses to dynamically adjust the stimulation voltage that is applied during a treatment phase, allowing for dynamic personalization of treatment. The dynamic changes in stimulation help to maximize comfort, enhance device performance, and enrich user experience.
- 美國專利12,011,592和歐洲專利EP3615133，均名爲“微電流刺激裝置的自適應觸發器”，保護了公司用於識別首選治療點和觸發治療模式的設備和方法。觸發器可以以各種方式進行編程，以改善設備性能和使用便捷性。
- 歐洲專利EP3615134，名爲“自適應電路的鼻竇治療設備”，保護了公司用於在治療階段動態調整施加的刺激電壓的設備和方法，實現治療的動態個性化。刺激的動態變化有助於最大化舒適度、增強設備性能以及豐富用戶體驗。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。